Waiting for new medicines in Canada, Europe, and the United States: study finds Americans get better and faster access to innovative drugs

11 April 2024 - A recent study published by the Canadian Health Policy Institute examined the availability and wait times ...

Read more →

New target zero initiative aims to help improve access to new drugs

9 April 2024 - Target Zero is a new initiative that aims to improve the time to access for patients ...

Read more →

Let's have permanently quicker drug approvals

16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...

Read more →

Long waits for life saving drugs harming Canadians: report

13 May 2021 - Canadians wait 15 months longer on average for new and potentially life-saving medications compared to Americans ...

Read more →

Rapid qualitative evidence syntheses in health technology assessment: experiences, challenges, and lessons

9 October 2020 - Health care decision makers are increasingly demanding that health technology assessment is patient focused, and considers data ...

Read more →

Canadians will wait longer for new medicines if Health Canada gets its way

23 April 2019 - The intention is to lower prices; the net result will likely be longer wait times before new ...

Read more →

Additional embargo period following revised CDEC recommendations

17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...

Read more →

New drugs: patients are needlessly waiting 15 months too long

5 April 2018 - Regulatory obstacles entail an additional delay of 15 months on average between the moment when a ...

Read more →

Most Canadians get timely medical treatment: report

28 March 2017 - A report from the Canadian Institute for Health Information suggests that three of every four people in ...

Read more →

Introducing a common CADTH recommendation framework and establishing a minimum period of 120 calendar days for advance notification of anticipated submissions and resubmissions for CADTH Common Drug Review and pan-Canadian Oncology Drug Review Programs

23 March 2016 - CADTH will be implementing changes to the CDR Procedures and pCODR Procedures that will require all manufacturers/submitters ...

Read more →